Skip to content

Wednesday, May 31, 2023

Latest:

FROM THE LABS: Gene Tiam1 orchestrates the development of chronic neuropathic pain
Addressing hunger on the ground in Colombia
Is there hidden meaning in “madness”?
Changes in gene p16 create a permissive microenvironment for colon cancer growth
A new education and health sciences building, a new era for Baylor and the TMC

Baylor College of Medicine Blog Network

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

US FDA

Policywise

Direct-to-consumer BRCA testing: Can a reasonable decision still require caution?

March 21, 2018March 21, 201823andMe, BRCA, genetic testing, health policy, Mary Anderlik Majumder, US FDA

On March 6, the U.S. Food and Drug Administration (FDA) authorized 23andMe to expand its direct-to-consumer (DTC) genetic test to include selected variants in BRCA1

From the Labs Image of the Month

From the Labs: The Liver’s biliary tree